UBS raised the firm’s price target on Axis Capital (AXS) to $115 from $105 and keeps a Buy rating on the shares. UBS likes the defensive nature of P&C insurance heading into 1Q25 results, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXS:
- Axis Capital price target lowered to $114 from $120 at Keefe Bruyette
- Axis Capital price target raised to $120 from $118 at Keefe Bruyette
- Axis Capital price target raised to $118 from $115 at Keefe Bruyette
- Axis Capital management to meet with Roth MKM
- Axis Capital board approves up to $400M share repurchase program